Adamis Pharmaceuticals | Capitale Sociale E Riserve



Equity Capital And Reserves Cambiamento Data
Adma Biologics USD 349.02M 117.13M 2024-12
Cipla INR 311.93B 27.38B 2025-03
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 54.91M 5.57M 2024-12
CSL USD 20.55B 3.18B 2024-12
GlaxoSmithKline GBP 14.16B 486M 2025-03
Glaxosmithkline GBP 13.67B 337M 2024-12
Grifols EUR 5.88B 533.83M 2024-12
Merck USD 48.34B 2.02B 2025-03
Pfizer USD 90.34B 2.14B 2025-03
RedHill Biopharma USD 61K 2.01M 2024-06



Adamis Pharmaceuticals Capitale Sociale E Riserve - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Jul 2025.